Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11400091 AXL kinase inhibitors and use of the same

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114000910

Patent Inventor Names

Paul Flynn0

Steven L. Warner0

Adam Siddiqui-Jain0

Akihito Kiguchiya0

Akihito Nonoyama0

David J. Bearss0

Hiroki Umehara0

Jason Marc Foulks0

...

Date of Patent

August 2, 2022

Patent Application Number

170925210

Date Filed

November 9, 2020

Patent Citations

‌

US Patent 10125140 Crystalline forms of a bruton's tyrosine kinase inhibitor

‌

US Patent 10202356 JAK2 and ALK2 inhibitors and methods for their use

‌

US Patent 10016435 Use of inhibitors of Bruton's tyrosine kinase (Btk)

‌

US Patent 11013741 AXL kinase inhibitors and use of the same

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11400091 AXL kinase inhibitors and use of the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API